| 10/31/2026 09:30 |
TOB results for the Share Certificates, Etc. and Changes in the Parent Companies, Etc. and Correction to Notice of Specified Subsidiary Transfer |
| 09/30/2026 15:30 |
Execution of Share Transfer Agreement regarding Transfer of Elderly Care Business (Transfer of Shares Involving Changes in Specified Subsidiaries) |
| 09/15/2026 08:00 |
[Delayed]Notice Regarding Expression of Opinion in Support of the Tender Offer for the Share Certificates, Etc. of the Company by K891, Inc. and Recom |
| 09/14/2026 20:00 |
Notice Concerning Execution of Memorandum of Understanding regarding Transfer of Elderly Care Business (Transfer of Shares Involving Changes in Specif |
| 09/14/2026 20:00 |
Notice Concerning Revision of Interim and Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2027 (No Dividend) |
| 08/27/2026 17:00 |
Financial Results Briefing for Q1 Fiscal Year Ending March 31, 2027 |
| 08/17/2026 15:30 |
Notice Regarding Selection as a Constituent of the JPX-Nikkei Index 400 |
| 08/07/2026 15:30 |
Consolidated Financial Statements for the three months ended June 30, 2026 |
| 08/07/2026 15:30 |
Investor Meeting Presentation for the Three Months Ended June 30, 2026 |
| 07/15/2026 15:30 |
Notice Concerning Appeal of Shareholder Derivative Lawsuit |
| 06/25/2026 16:05 |
Notice Concerning Judgment in Shareholder Derivative Lawsuit |
| 06/25/2026 15:30 |
Corporate Governance Report |
| 06/25/2026 15:30 |
Notice Concerning Disclosure of Matters Relating to Controlling Shareholder, etc. |
| 06/25/2026 15:30 |
Notice Concerning Financial Results of Unlisted Parent Company, etc. |
| 06/19/2026 15:30 |
Notice Concerning Partial Revision of Basic Policy for Establishing Internal Control System |
| 06/03/2026 08:00 |
Notice of the 53rd Ordinary General Shareholders' Meeting and Meeting Materials |
| 05/22/2026 15:30 |
Financial Results Briefing for Fiscal Year Ended March 2026 |
| 05/15/2026 15:30 |
Notice Concerning Changes in Members of Board of Directors |
| 05/15/2026 15:30 |
Notice Concerning Dividend of Surplus |
| 05/15/2026 15:30 |
Investor Meeting Presentation for the fiscal year ended March 31, 2026 |
| 05/15/2026 15:30 |
Consolidated Financial Statements for the Fiscal Year 2025 |
| 03/09/2026 16:00 |
Leopalace21 Selected as Health & Productivity Stock 2026; Certified as Health & Productivity Management Organizations(White 500) |
| 03/04/2026 15:30 |
Notice Concerning Changes in Organizational Structure and Executive Officers |
| 02/20/2026 15:30 |
Financial Results Briefing for Q3 Fiscal Year Ending March 31, 2026 |
| 02/13/2026 15:30 |
Consolidated Financial Statements for the nine months ended December 31, 2025 |
| 02/13/2026 15:30 |
Notice Concerning Refinancing of Funds Borrowed from Mizuho Bank, Ltd. and Signing of Loan Agreement with Financial Covenants |
| 02/13/2026 15:30 |
Investor Meeting Presentation for the Nine Months Ended December 31, 2025 |
| 11/25/2025 15:30 |
Financial Results Briefing for Q2 Fiscal Year Ending March 31, 2026 |
| 11/14/2025 15:30 |
Consolidated Financial Statements for the six months ended September 30, 2025 |
| 11/14/2025 15:30 |
Investor Meeting Presentation for the Six Months Ended September 30, 2025 |
| 11/14/2025 15:30 |
Notice Concerning Differences between Earnings Forecasts and Actual Results for the First Half and Revisions of Earnings Forecasts for FY2025 |
| 11/14/2025 15:30 |
Notice Concerning Interim Dividend of Surplus |
